Skip to content

Oncogenic PIK3CA enhances collective migration of mammary epithelial cells through ERK wave propagation.

Aug 2026 · Journal of Cell Science · Vol 139 15 · 1 citation · 72 references
Medicine

TL;DR

Analysis of factors regulating collective cell migration of genome-edited MCF10A cell lines carrying hotspot PIK3CA mutations suggest that polarized actomyosin contractility and pulsatile ERK activation must be constrained in the territory of a phase diagram compatible with mechanotransduction of ERK waves across cell-cell junctions to achieve highly coordinated and efficient collective migration.

Abstract

Oncogenic mutations of the PIK3CA gene, which encodes the catalytic subunit of the phosphatidylinositol 3-kinase (PI3K) enhance cell migration via ERK (ERK1 and ERK2, also known as MAPK3 and MAPK1, respectively) activation. We analyzed the factors regulating collective cell migration (CCM) of genome-edited MCF10A cell lines carrying hotspot PIK3CA mutations E545K or H1047R. H1047R enhanced CCM and promoted the propagation of waves of ERK activity backwards from the wound edge, whereas E545K impaired both coordinated CCM and ERK activity wave formation. The distance traveled by ERK activity waves correlated with directional persistence of migrating cells. Inhibition of cell contractility stimulated ERK wave propagation and efficient CCM of E545K cells but impaired ERK waves and CCM in control cells. Impaired ERK wave propagation was consistently associated with non-linear cell-cell junctions and the loss of polarized distribution of actomyosin. Taken together, these analyses suggest that polarized actomyosin contractility and pulsatile ERK activation must be constrained in the territory of a phase diagram compatible with mechanotransduction of ERK waves across cell-cell junctions to achieve highly coordinated and efficient collective migration.

View source

Similar papers

Sep 2026

Abstract A048: TGFBR2 dysfunction rewires cell cycle, MAPK signaling, and migration in pancreatic cancer

The results suggest that PKT tumor aggressiveness may be attributed to preferential activation of cell cycle-associated programs over EMT-associated migration programs, and support G1/S cell cycle regulation as a potential vulnerability for combination therapy with KRASG12D inhibition or chemotherapy in TGFBR2-mutant o...

Vincent Lam, R. M. Walsh, Bailey A. Bye et al. · 0 citations
Open access Sep 2026

Rewiring of Integrin Signaling and Cell-cycle Deregulation Drive SMARCB1-Deficient Epithelioid Sarcoma

Epithelioid sarcoma (EPS) is an aggressive soft-tissue sarcoma characterized by loss of the chromatin- remodeling subunit SMARCB1. The oncogenic programs driving EPS remain poorly understood. Through CRISPR loss-of-function screens, we identified conserved dependencies on integrin signaling components and cyclin-depend...

Ryo Miyamoto, Jiyeon Park, Gabrielle H. Dwosh et al. · 0 citations
Open access Sep 2026

Cofilin/RhoA and CREB synergistically promote invasion and migration of polyploid giant cancer cells in colorectal cancer

Colorectal cancer (CRC) is associated with high mortality and poor survival. Polyploid giant cancer cells (PGCCs) are a subset of cancer cells that drive tumor initiation and progression. In this study, high-concentration CoCl₂ treatment was used to induce Hct116 and LoVo cells to form PGCCs with daughter cells (PDCs),...

Yi-Di Ning, Kai Liu, Jing Xu et al. · 0 citations
Sep 2026

MEK/ERK signaling and Bcl-2 family protein changes in influenza-infected cells with differing sulfatide levels.

Influenza A virus (IAV) exploits host pathways to maximize progeny production. Sulfatide, a sulfated glycosphingolipid on the plasma membrane, has been implicated in enhanced influenza replication; however, the underlying host factors remain unclear. Using sulfatide-low COS7 cells, sulfatide-enriched SulCOS1 cells, and...

Shintaro Onishi, Yuuki Kurebayashi, Tadanobu Takahashi et al. · 0 citations
Open access Sep 2026

ACTB promotes ESCC progression by regulating the AKT-mTOR signaling pathway through an m6A-dependent mechanism.

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and the upstream regulatory mechanisms driving oncogenic signaling remain insufficiently defined. In this study, we identify a previously unrecognized nuclear function of the cytoskeletal protein ACTB in promoting ESCC prog...

Yun-Shan Jiang, Dan Zhao, D. Liao et al. · 0 citations
Sep 2026

Abstract B050: ERK1 splicing switch triggers lethal hyperactivation and overcomes KRAS inhibitor resistance in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second leading cause of cancer death in the United States by 2040. Oncogenic KRAS, present in ∼90% of PDACs, drives tumor growth through MAPK signaling and ERK1/2 activation. While pan-RAS and mutant-selective KRAS inhibitors can produce initial r...

Luisa F. Escobar-Hoyos, Md Siraj Afjalus, Deanne E. Yugawa et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.